Intravenous thrombolysis after reversal of dabigatran by idarucizumab: a moment to be a pioneer

Intravenous thrombolysis after reversal of dabigatran by idarucizumab: a moment to be a pioneer Acta Neurol Belg (2017) 117:753–755 DOI 10.1007/s13760-017-0751-5 LETTER TO THE EDITOR Intravenous thrombolysis after reversal of dabigatran by idarucizumab: a moment to be a pioneer 1 1 2 3 4 • • • • G. Turine A. Peeters C. Hermans S. Eeckhoudt T. Duprez Received: 18 November 2016 / Accepted: 17 January 2017 / Published online: 30 January 2017 Belgian Neurological Society 2017 Keywords Ischemic stroke  Intravenous thrombolysis  dabigatran 110 mg, which he immediately gave her. At Dabigatran  Idarucizumab 5.00 AM, he observed a right facial palsy. As symptoms did not resolve spontaneously, he called the emergency medical service. On admission, blood pressure was Introduction 170/100 mmHg, glycemia was 176 mg/dL, and cardiac rate was 98, irregular. Neurological examination showed Effective anticoagulation is a contraindication for intra- drowsiness, a right-sided paresis of face, arm, and leg, venous thrombolysis (IVT) with recombinant tissue plas- together with right-sided homonymous hemianopsia and minogen activator (rt-PA). We here report our first and severe aphasia. The total NIHSS score was 17. successful experience of systemic thrombolysis a few Brain computed tomography (CT) excluded an minutes after reversal of dabigatran by idarucizumab. intracranial hemorrhage and demonstrated an insular and left frontal acute http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Acta Neurologica Belgica Springer Journals

Intravenous thrombolysis after reversal of dabigatran by idarucizumab: a moment to be a pioneer

Loading next page...
 
/lp/springer_journal/intravenous-thrombolysis-after-reversal-of-dabigatran-by-idarucizumab-XIv7EfGpR2
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by Belgian Neurological Society
Subject
Biomedicine; Neurosciences; Neurology; Neuroradiology; Medicine/Public Health, general
ISSN
0300-9009
eISSN
2240-2993
D.O.I.
10.1007/s13760-017-0751-5
Publisher site
See Article on Publisher Site

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial